Research by Design, LLC | Chicago, IL

Research site

Location

10801 South Western Avenue, Suite 201, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

BI 685509

Relmapirazin

MB-102

Calcifediol

PF-07321332

Ritonavir

Finerenone

MK-8527-008

CTAP101

sodium chloride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Research by Design

Verified by this site

Active trials

6 of 30 total trials

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease

Enrolling

Proteinuric Kidney Disease

Drug: MZE829

Locations recently updated

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

The purpose of this 26 week study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney di...

Enrolling

CKD

Metabolic Acidosis

Drug: Placebo

Drug: Veverimer

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease (ALPINE 1)

Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys' ability to w...

Active, not recruiting

Chronic Kidney Disease

Drug: BAY3283142

Drug: Placebo

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting

Obesity

Drug: Placebo

Drug: survodutide

Locations recently updated

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication...

Enrolling

Chronic Kidney Disease

Drug: Vicadrostat

Drug: Empagliflozin

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Active, not recruiting

Chronic Kidney Disease

Inflammation

Drug: Placebo (Ziltivekimab B)

Drug: Placebo (Ziltivekimab C)